Advertisement
News
Advertisement

Nuvera Biosciences nears breast cancer survival prediction test

Fri, 06/03/2011 - 8:38am
Mass High Tech: The Journal of New England Technology

Nuvera Biosciences, a cancer diagnostics company, announced positive results for a breast cancer test that is designed to predict which patients may be cured by chemotherapy. The Woburn-based company says the test, which has now been studied in two large trials, can help guide treatment for newly diagnosed patients.

Company officials say currently, determining which patients will respond best to chemotherapy versus other treatment options – including experimental therapies – is a challenge.

SOURCE

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading